RxSight, Inc. to Present at the Bank of America Healthcare Conference

4/30/25 4:05:00 PM ET

Ophthalmic Goods

Health Care

Get the next $RXST alert in real time by email

ALISO VIEJO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- (NASDAQ:RXST) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Bank of America Healthcare Conference in Las Vegas.

RxSight's management is scheduled to present on Wednesday, May 14, 2025, at 3:40 p.m. Pacific Time / 6:40 p.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation at: https://investors.rxsight.com/.

About RxSight, Inc.

RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight^® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens^® (LAL^®/LAL+^®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.

Company Contact:

Shelley B. Thunen

Chief Financial Officer

[email protected]

Investor Relations Contact:

Oliver Moravcevic

VP, Investor Relations

[email protected]

Get the next $RXST alert in real time by email

Recent Analyst Ratings for

$RXST

Date	Price Target	Rating	Analyst
5/19/2025	$25.00	Equal Weight → Overweight	Wells Fargo
4/15/2025	$18.00	Neutral	Piper Sandler
4/9/2025	$16.00	Buy → Neutral	UBS
4/4/2025	$40.00 → $17.00	Overweight → Underweight	Analyst
4/3/2025	$36.00 → $22.00	Buy → Underperform	BofA Securities
12/20/2024	$65.00 → $40.00	Buy → Hold	Stifel
12/11/2024	$56.00 → $42.00	Overweight → Equal Weight	Wells Fargo
12/6/2024	$52.00	Buy	UBS

More analyst ratings

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Chat with this insight

Recent Analyst Ratings for
$RXST

$RXST
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Corley Jesse Anderson bought $100,004 worth of shares (3,210 units at $31.15) (SEC Form 4)

Director Corley Jesse Anderson bought $1,014,570 worth of shares (22,476 units at $45.14), increasing direct ownership by 18% to 38,438 units (SEC Form 4)

Tammenoms Bakker Juliet bought $305,456 worth of shares (5,000 units at $61.09), increasing direct ownership by 17% to 34,840 units (SEC Form 4)

RxSight, Inc. to Present at the Bank of America Healthcare Conference

Chat with this insight

Recent Analyst Ratings for $RXST

$RXST Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Corley Jesse Anderson bought $100,004 worth of shares (3,210 units at $31.15) (SEC Form 4)

Director Corley Jesse Anderson bought $1,014,570 worth of shares (22,476 units at $45.14), increasing direct ownership by 18% to 38,438 units (SEC Form 4)

Tammenoms Bakker Juliet bought $305,456 worth of shares (5,000 units at $61.09), increasing direct ownership by 17% to 34,840 units (SEC Form 4)

Recent Analyst Ratings for
$RXST

$RXST
Insider Purchases